Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

Combined Therapy Ups Brain Cancer Survival

Posted on: Wednesday, 31 October 2007, 12:00 CDT

Swiss researchers have found that combining radiation and chemotherapy can quadruple survival time for patients with brain cancer.

Dr. Rene-Olivier Mirimanoff of the University Hospital Center of Vaud in Lausanne, Switzerland, led the study of patients with glioblastoma multiforme, or GBM -- a rapidly progressing fatal type of brain cancer.

The researchers found GBM patients treated with the drug temozolomide and radiation therapy were more than four times as likely to survive four years after diagnosis, compared with patients receiving only radiation treatment. GBM patients typically live no longer than 12 months after diagnosis, with nearly no survivors after two years.

Considering how quickly this type of cancer grows, patients who live four or five years after diagnosis are indeed considered long-term cancer survivors, said Mirimanoff.

The study was presented this week in Los Angeles during the 49th annual meeting of the American Society for Therapeutic Radiology and Oncology.


Source: United Press International

More News in this Category


Related Articles



Rating: 2.7 / 5 (3 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required